Installation
About
The nonparametric two-stage Bayesian adaptive design is a novel phase II clinical trial design for finding the minimum effective dose (MinED). This design is motivated by the top priority and concern of clinicians when testing a new drug, which is to effectively treat patients and minimize the chance of exposing them to subtherapeutic or overly toxic doses. It is used to design single-agent trials.
Key Metrics
Downloads
Yesterday | 4 -43% |
Last 7 days | 33 -23% |
Last 30 days | 140 +9% |
Last 90 days | 400 -35% |
Last 365 days | 1.873 -10% |